The Xolair Pregnancy Registry (EXPECT): Perinatal outcomes among pregnant women with asthma treated with omalizumab (Xolair) compared against those of a cohort of pregnant women with moderate-to-severe asthma

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology 2019-02, Vol.143 (2), p.AB103-AB103
Main Authors: Namazy, Jennifer A., Blais, Lucie, Andrews, Elizabeth B., Scheuerle, Angela E., Cabana, Michael D., Thorp, John M., Veith, Joachim H., Umetsu, Dale T., Sun, Diana, Kaufman, Derrick G., Covington, Deborah L., Mukhopadhyay, Santanu, Fogel, Robert B., Lopez-Leon, Sandra, Spain, Vic
Format: Article
Language:English
Subjects:
Asthma
Congenital diseases
Health risk assessment
Immunoglobulin E
Immunotherapy
Monoclonal antibodies
Pregnancy
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2018.12.312